Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4149 USD | +2.95% | -2.12% | -5.68% |
05-16 | Transcript : AIM ImmunoTech Inc., Q1 2024 Earnings Call, May 16, 2024 | |
04-29 | AIM ImmunoTech Says Safety Evaluation of First Dose Level of Pancreatic Cancer Study Completed | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.68% | 20.51M | |
+9.77% | 115B | |
+11.85% | 106B | |
-2.88% | 21.96B | |
-14.11% | 21.87B | |
-5.29% | 19.21B | |
-3.02% | 18.08B | |
-38.57% | 17.71B | |
+6.38% | 14.32B | |
+35.48% | 12.42B |
- Stock Market
- Equities
- AIM Stock
- News AIM ImmunoTech Inc.
- Transcript : Hemispherx Biopharma, Inc., Q1 2016 Earnings Call, May 17, 2016